30 April 2020

Safety Updates & Recalls for Medical & Pharmaceutical Products

Reference: CIR-2019-00000251

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

• Withdrawal marketing authorization Lartruvo ( Olaratumab )
• Recall medical device Miller Balloon Atrioseptostomy Catheter & Fogarty Dilation Atrioseptostomy Catheter
• Recall number of lots for medical devices
• Medical device recall EV 1000 Clinical Platform
• Recall medical device Coulter Life Sciences
• Safety update of a pharmaceutical products

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Withdrawal marketing authorization Lartruvo ( Olaratumab ).pdf:

View Document

Recall medical device Miller Balloon Atrioseptostomy Catheter _ Fogarty Dilation Atrioseptostomy Catheter.pdf:

View Document

Recall number of lots for medical devices.pdf:

View Document

Medical device recall EV 1000 Clinical Platform.pdf:

View Document

Recall medical device Coulter Life Sciences.pdf:

View Document

Safety update of a pharmaceutical products.pdf:

View Document